Abdominal Aortic Aneurysm Treatment Market

Key Takeaways

Surgery is expected to remain the largest treatment segment, accounting for 62.0% of the Abdominal Aortic Aneurysm Treatment Market in 2026. Among end users, Hospitals lead with a 68.0% share, while Elderly Patients represent the largest patient type, accounting for 46.0% of the market. The competitive landscape includes prominent companies such as Medtronic, Johnson & Johnson, and Cook Medical, alongside Endologix, Boston Scientific, Terumo, Abbott Laboratories, and Bard Peripheral Vascular.